Objective: What initiates the pubertal process in humans and other mammals is still unknown. We hypothesized that gene(s) taking roles in triggering human puberty may be identified by studying a cohort of idiopathic hypogonadotropic hypogonadism (IHH).
Methods: A cohort of IHH cases was studied based on autozygosity mapping coupled with whole exome sequencing.
Results: Our studies revealed three independent families in which IHH/delayed puberty is associated with inactivating SRA1 variants. SRA1 was the first gene to be identified to function through its protein as well as noncoding functional ribonucleic acid products. These products act as co-regulators of nuclear receptors including sex steroid receptors as well as SF-1 and LRH-1, the master regulators of steroidogenesis. Functional studies with a mutant SRA1 construct showed a reduced co-activation of ligand-dependent activity of the estrogen receptor alpha, as assessed by luciferase reporter assay in HeLa cells.
Conclusion: Our findings strongly suggest that SRA1 gene function is required for initiation of puberty in humans. Furthermore, SRA1 with its alternative products and functionality may provide a potential explanation for the versatility and complexity of the pubertal process.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096466 | PMC |
| http://dx.doi.org/10.4274/jcrpe.3248 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
From biological marker to clinical application: the role of anti-Müllerian hormone (AMH) for delayed puberty and idiopathic non-obstructive azoospermia in males.
Endocr Connect
January 2025
X Jiang, Human Sperm Bank, Sichuan University West China Second University Hospital, Chengdu, China.
Anti-Müllerian hormone (AMH), a biomarker secreted by Sertoli cells in the testes, has emerged as a critical indicator of male reproductive function with significant clinical application potential. AMH reflects Sertoli cell activity and plays a pivotal role across different stages of male gonadal function. Firstly, in prepubertal males, AMH levels are crucial for assessing testicular development and the progression of puberty, with delayed or insufficient AMH secretion often being associated with disorders like delayed puberty.
View Article and Find Full Text PDF[Deterioration of male reproductive function: methods and algorithms of etiopathogenetic and empirical treatment of the main clinical forms].
Urologiia
November 2024
Men's Health Clinic, University Clinic of Lomonosov Moscow State University and Department of Urology and Andrology, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia.
In half of the cases, a decrease in the quantity and/or quality of spermatozoa is the cause of infertility. The pathogenesis of such disorders is multifactorial, often unknown, and data on the treatment efficiency are still contradictory. Based on the recent high-level evidences (randomized studies and meta-analyses), the real clinical efficiency of various surgical and conservative treatment methods for the main clinical forms of male reproductive dysfunction, including hypo- and hypergonadotropic hypogonadism, secretory and obstructive azoospermia, retrograde ejaculation and anejaculation, pathospermia associated with varicocele, and idiopathic forms, is analyzed.
View Article and Find Full Text PDFA Case of Idiopathic Central Diabetes Insipidus and a Mosaic Form of Turner Syndrome.
Cureus
October 2024
Department of Endocrinology and Metabolic Diseases, Medical University of Plovdiv, Plovdiv, BGR.
Article Synopsis
- Central diabetes insipidus is caused by a loss of function in vasopressinergic neurons, leading to insufficient secretion of arginine vasopressin, resulting in symptoms like excessive urination and thirst.
- Turner syndrome, characterized by a missing or incomplete X chromosome, can sometimes occur alongside central diabetes insipidus, although this combination is very rare.
- A reported case of a 22-year-old female with both conditions highlighted the need for careful diagnosis and treatment, with successful management through vasopressin replacement after confirming central diabetes insipidus through tests and imaging.
Pharmacological therapies for male infertility.
Pharmacol Rev
October 2024
Global Andrology Forum, United States
Male factor infertility is a multifaceted problem that affects approximately 50% of couples suffering from infertility. Causes of male infertility include endocrine disturbances, gonadotoxins, genetic abnormalities, varicocele, malignancies, infections, congenital or acquired urogenital abnormalities, iatrogenic factors, immunological factors, and idiopathic reasons. There are a variety of treatment options for male infertility, depending on the underlying cause(s).
View Article and Find Full Text PDFPrimary ovarian insufficiency: update on clinical and genetic findings.
Front Endocrinol (Lausanne)
October 2024
Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.
Article Synopsis
- Primary ovarian insufficiency (POI) affects about 3.7% of women under 40, leading to fertility challenges and impacting overall health and quality of life.
- The causes of POI can be unclear, but there is a significant genetic factor involved, particularly linked to defects on the X chromosome.
- This review discusses the clinical features of POI, associated genetic factors, and management strategies for preserving fertility in those at risk.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!